Pharmaceutical agents for treatment of leishmaniasis: a patent landscape-Reference-Cited by-同舟云学术

Pharmaceutical agents for treatment of leishmaniasis: a patent landscape

Published:2020-07-20 Issue:8 Volume:30 Page:633-641
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Barbosa Gomes de Carvalho Yasmim Maria¹^ORCID,Shanmugam Saravanan¹^ORCID,Batista Mayrton Santos¹,Serafini Mairim Russo¹^ORCID,Araújo Adriano Antunes De Souza¹,Quintans Júnior Lucindo José¹^ORCID

Affiliation:

1. Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brazil

National Council for Scientific and Technological Development – CNPq and FAPITEC-SE

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2020.1789100

Reference47 articles.

1. Leishmaniasis: a review

2. Need for sustainable approaches in antileishmanial drug discovery

3. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

4. Leishmania treatment and prevention: Natural and synthesized drugs

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Leishmania activity and molecular docking of unusual flavonoids-rich fraction from Arrabidaea brachypoda (Bignoniaceae);Molecular and Biochemical Parasitology;2024-09

2. Nicotinamide mitigates visceral leishmaniasis by regulating inflammatory response and enhancing lipid metabolism;Parasites & Vectors;2024-07-06

3. Investigation of the Potential Targets behind the Promising and Highly Selective Antileishmanial Action of Synthetic Flavonoid Derivatives;ACS Infectious Diseases;2023-09-29

4. Recent patents in the treatment and prevention of leishmaniasis;Pharmaceutical Patent Analyst;2023-09

5. Multi-target withaferin-A analogues as promising anti-kinetoplastid agents through the programmed cell death;Biomedicine & Pharmacotherapy;2023-08